Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
FibriCheck, a Belgium-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) for its artificial intelligence-powered digital platform that uses smartphone cameras to obtain heart rhythm measurements.

FDA clears heart rhythm AI that turns smartphones into medical devices

FibriCheck has been increasing its presence in the United States in anticipation of this approval, opening a new office and partnering with U.S. hospitals. 

Video interview with Sahil Parikh, MD, FSCAI, director of endovascular services, New York-Presbyterian Columbia University Irving Medical Center and associate professor of medicine at Columbia University, who discusses the disparities in PE treatments in the REAL-PE study

REAL-PE highlights disparities in pulmonary embolism care

Sahil Parikh, MD, director of endovascular services, New York-Presbyterian, explains details from the big-data REAL-PE study comparing mechanical thrombectomy to ultrasound assisted catheter thrombolysis.

PCI interventional cardiology

‘Failure to rescue’ after PCI: 20% of patients die when complications occur

Major complications are rare during percutaneous coronary intervention. When they do occur, however, the in-hospital mortality rate is relatively high. 

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Prosthesis-patient mismatch after TAVR makes minimal impact on long-term outcomes

Researchers tracked SWEDEHEART data from more than 8,000 TAVR patients treated from 2008 to 2022. Overall, they said, PPM after TAVR was rare, and its impact on outcomes was "negligible."

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

Volta Medical, GE Healthcare partner on AI-powered AFib treatments

Under this new arrangement, Volta Medical's AI software will be integrated into GE Healthcare offerings to improve AFib outcomes. 

old woman or doctor shaking hands with patient

Get SMART: Cardiologist says new TAVR data changed his perspective on treating women with symptomatic severe AS

Sponsored by Medtronic

Physicians and researchers complete thousands of clinical trials each year, but some findings prove far more significant than others. For cardiologist Dharmesh Patel, MD, the results of the SMART trial have changed the way he’s managing and recommending treatment for women with symptomatic severe aortic stenosis.

Magenta Medical, an Israeli healthcare technology company, has closed a funding round worth $105 million.

Medical device company raises another $105M for new-look heart pump

Magenta Medical plans to use some of the new financing to secure FDA approval for its Elevate LVAD. Novo Holdings, the controlling shareholder of international healthcare company Novo Nordisk, led the funding round.

suzanne_baron_md.png

Q&A: Interventional cardiologist breaks down SMART data and TAVR valve performance in patients with small annuli

Sponsored by Medtronic

Some of the most talked about data at ACC.24 were the results of a late-breaking clinical trial comparing different transcatheter aortic valve replacement (TAVR) valves in patients with a small aortic annulus. 

Displaying 393 - 400 of 5928
Design by Adaptive Theme